bret stephens

Drives strategic design and execution of over 24 global Investigator Sponsored Studies (ISS) oncology trials across various indications. Leads clinical innovation programs for novel assays, acting as the clinical operations lead for first-in-pipeline programs supporting commercial readiness and clinical utility validation. Presents executive briefings to VP and CMO with study metrics, site perform

Coordinated and tracked all biospecimen operational activities across multiple Investigator Sponsored Studies (ISS), ensuring timely delivery of results and protocol compliance. Maintained oversight of study sample management, including tracking from accessioning to reporting, reconciliation of incomplete specimen sets, and return of residual samples. Collaborated cross-functionally with various t

Designed and led the Liquid Biopsy Program for early detection of pancreatic and colorectal cancer, including study design, protocol development, and cross-functional trial execution. Developed a novel cloud-based biobank system for over 127,000 biospecimens across 4,500+ patients, improving traceability and compliance with GCP, HIPAA, IRB, and FDA regulations. Managed clinical research operations

Established an intern program for local second-year nursing students to gain real-world experience in the ER by appropriately assessing physicians and department needs. Performed comprehensive administrative duties, which involved hiring, training, scheduling, and overall program management.

Conducted clinical research focused on the bioinorganic chemistry of proteins involved in melanoma cancer and red blood cells. Collaborated with a pharmaceutical company to develop a better method of delivering medicine by genetically modifying myoglobin proteins to act as targeted delivery mechanisms.

Concentrated in Bioethics. Completed post-baccalaureate studies in 2016.

Focused on Bioinorganic Chemistry. Completed the Bachelor of Science degree in 2014.